Other

Prepaid development costs

Neurocrine Biosciences Prepaid development costs increased by 25.2% to $69.60M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026May 5, 2026
Metric ID: other_prepaid_development_costs

Historical Data

2 periods
 Q4 '25Q1 '26
Value$55.60M$69.60M
QoQ Change—+25.2%
Range$55.60M – $69.60M

Frequently Asked Questions

What is Neurocrine Biosciences's prepaid development costs?
Neurocrine Biosciences (NBIX) reported prepaid development costs of $69.60M in Q1 2026.